Survival outcome of intermediate risk neuroblastoma at Children Cancer Hospital Egypt
Conclusion A very high rate of survival is currently achievable in patients with intermediate risk neuroblastoma by chemotherapy or chemotherapy and surgery. In addition to response, our plan is to adopt biologically-based treatment to reduce treatment-induced complications among survivors.
Source: Journal of the Egyptian National Cancer Institute - Category: Cancer & Oncology Source Type: research
More News: Biology | Brain | Cancer | Cancer & Oncology | Chemotherapy | Children | Egypt Health | Neuroblastoma | Neurology | Neurosurgery | Pathology | Pediatrics | Statistics | Study